Direkt zum Inhalt
  1. Publizieren |
  2. Suche |
  3. Browsen |
  4. Neuzugänge rss |
  5. Open Access |
  6. Rechtsfragen |
  7. EnglishCookie löschen - von nun an wird die Spracheinstellung Ihres Browsers verwendet.

Impact of Variant Notch Ligands on Chronic Liver Diseases

Dewidar, Bedair Ibrahim Soliman

[thumbnail of Thesis_Bedair_Dewidar A compliance.pdf] PDF, Englisch
Download (11MB) | Nutzungsbedingungen

Zitieren von Dokumenten: Bitte verwenden Sie für Zitate nicht die URL in der Adresszeile Ihres Webbrowsers, sondern entweder die angegebene DOI, URN oder die persistente URL, deren langfristige Verfügbarkeit wir garantieren. [mehr ...]

Abstract

Introduction To date, the roles of individual Notch ligands in liver injury are not well defined. The current study investigated whether and how Notch ligands DLL4 and JAG1 affect liver injury. Methods We examined the expression of Notch ligands and receptors by immunohistochemistry (IHC) in the liver samples of 26 patients with HBV-induced liver cirrhosis. The function of recombinant Dll4 (rDll4) and rJag-1 was investigated in vivo in carbon tetrachloride (CCl4) and bile duct ligation (BDL) animal models and in vitro in hepatocytes, Kupffer cells (KCs), and hepatic stellate cells (HSCs). Results DLL4 and JAG1 were the only Notch ligands expressed in liver sinusoids of examined patients. In the CCl4 animal model, rDll4 and rJag-1 ameliorated liver fibrosis, decreased infiltration of inflammatory cells, and inhibited apoptosis. On the contrary, rDll4 and rJag-1 caused rapid death of all BDL mice within 1 week. rDll4 inhibited the expression of chemokine ligand 2 (CCL2) and infiltration of inflammatory cells in livers of BDL mice, whereas rJag-1 did not have any impact on inflammatory cells infiltration and CCL2 expression. In macrophages and HSCs, rDll4 inhibited LPS-induced CCL2 expression, whereas rJag-1 did not impact CCL2 expression. Inhibition of inflammation by rDll4 caused unrestricted bile infarct and rapid death of BDL animals. Recombinant Ccl2 (rCcl2) restored the infiltration of inflammatory cells, decreased the size of bile infarcts and rescued rDll4-treated BDL animals from death. In ACLF patients, DLL4 expression was negatively associated with expression of CCL2. In contrast to rDll4-treated BDL animals, rCcl2 did not rescue rJag-1-treated BDL animals. Conclusion Etiology determines the effects of DLL4 and JAG1 on liver injury. DLL4 inhibits liver inflammation through inhibiting CCL2, a key chemokine for recruitment of inflammatory cells. How Jag-1 impact liver injury requires further investigation.

Dokumententyp: Dissertation
Erstgutachter: Dooley, Prof. Dr. rer. nat. Steven
Tag der Prüfung: 5 Dezember 2018
Erstellungsdatum: 18 Dez. 2018 13:37
Erscheinungsjahr: 2018
Institute/Einrichtungen: Medizinische Fakultät Mannheim > Medizinische Klinik - Lehrstuhl für Innere Medizin II
DDC-Sachgruppe: 610 Medizin
Normierte Schlagwörter: Notch ligands, Liver fibrosis, ACLF
Freie Schlagwörter: DLL4, JAG1
Leitlinien | Häufige Fragen | Kontakt | Impressum |
OA-LogoDINI-Zertifikat 2013Logo der Open-Archives-Initiative